[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 893 Referred in House (RFH)]
1st Session
S. 893
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 26, 2005
Referred to the Committee on Energy and Commerce, and in addition to
the Committee on the Judiciary, for a period to be subsequently
determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned
_______________________________________________________________________
AN ACT
To make technical corrections in the Anabolic Steroid Control Act of
2004.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. TECHNICAL CORRECTIONS.
Section 102(41)(A) of the Controlled Substances Act (21 U.S.C.
802(41)(A)), as amended by the Anabolic Steroid Control Act of 2004
(Public law 108-358), is amended by--
(1) striking clause (xvii) and inserting the following:
``(xvii) 13b-ethyl-17b-hydroxygon-4-en-3-one;''; and
(2) striking clause (xliv) and inserting the following:
``(xliv) stanozolol (17a-methyl-17b-hydroxy-[5a]-androst-2-
eno[3,2-c]-pyrazole);''.
Passed the Senate April 25, 2005.
Attest:
EMILY J. REYNOLDS,
Secretary.